Cargando…
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781803/ https://www.ncbi.nlm.nih.gov/pubmed/35057048 http://dx.doi.org/10.3390/pharmaceutics14010152 |
_version_ | 1784638167170678784 |
---|---|
author | Baracaldo-Santamaría, Daniela Ariza-Salamanca, Daniel Felipe Corrales-Hernández, María Gabriela Pachón-Londoño, Maria José Hernandez-Duarte, Isabella Calderon-Ospina, Carlos-Alberto |
author_facet | Baracaldo-Santamaría, Daniela Ariza-Salamanca, Daniel Felipe Corrales-Hernández, María Gabriela Pachón-Londoño, Maria José Hernandez-Duarte, Isabella Calderon-Ospina, Carlos-Alberto |
author_sort | Baracaldo-Santamaría, Daniela |
collection | PubMed |
description | Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause neuronal death through mechanical forces that disrupt cell architecture, and other secondary consequences through mechanisms such as inflammation, oxidative stress, programmed cell death, and, most importantly, excitotoxicity. This review aims to provide a comprehensive understanding of the many classical and novel pathways implicated in tissue damage following TBI. We summarize the preclinical evidence of potential therapeutic interventions and describe the available clinical evaluation of novel drug targets such as vitamin B12 and ifenprodil, among others. |
format | Online Article Text |
id | pubmed-8781803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87818032022-01-22 Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside Baracaldo-Santamaría, Daniela Ariza-Salamanca, Daniel Felipe Corrales-Hernández, María Gabriela Pachón-Londoño, Maria José Hernandez-Duarte, Isabella Calderon-Ospina, Carlos-Alberto Pharmaceutics Review Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause neuronal death through mechanical forces that disrupt cell architecture, and other secondary consequences through mechanisms such as inflammation, oxidative stress, programmed cell death, and, most importantly, excitotoxicity. This review aims to provide a comprehensive understanding of the many classical and novel pathways implicated in tissue damage following TBI. We summarize the preclinical evidence of potential therapeutic interventions and describe the available clinical evaluation of novel drug targets such as vitamin B12 and ifenprodil, among others. MDPI 2022-01-08 /pmc/articles/PMC8781803/ /pubmed/35057048 http://dx.doi.org/10.3390/pharmaceutics14010152 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Baracaldo-Santamaría, Daniela Ariza-Salamanca, Daniel Felipe Corrales-Hernández, María Gabriela Pachón-Londoño, Maria José Hernandez-Duarte, Isabella Calderon-Ospina, Carlos-Alberto Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title | Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title_full | Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title_fullStr | Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title_full_unstemmed | Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title_short | Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside |
title_sort | revisiting excitotoxicity in traumatic brain injury: from bench to bedside |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781803/ https://www.ncbi.nlm.nih.gov/pubmed/35057048 http://dx.doi.org/10.3390/pharmaceutics14010152 |
work_keys_str_mv | AT baracaldosantamariadaniela revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside AT arizasalamancadanielfelipe revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside AT corraleshernandezmariagabriela revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside AT pachonlondonomariajose revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside AT hernandezduarteisabella revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside AT calderonospinacarlosalberto revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside |